Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants

This publication has 8 references indexed in Scilit:

• Betamethasone Increases Pulmonary Compliance in Part by Surfactant-Independent Mechanisms in Preterm Rabbits
  Pediatric Research, 1987
• Effects of Maternal Treatment with Corticosteriods, T₃, TRH, and Their Combinations on Lung Function of Ventilated Preterm Rabbits with and without Surfactant Treatments
  American Review of Respiratory Disease, 1987
• Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits.
  Journal of Clinical Investigation, 1987
• DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASE
  The Lancet, 1987
• Prophylactic Treatment of Very Premature Infants with Human Surfactant
  New England Journal of Medicine, 1986
• Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial
  The Journal of Pediatrics, 1985
• Dihydrotestosterone Inhibits Fetal Rabbit Pulmonary Surfactant Production
  Journal of Clinical Investigation, 1982
• Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome**See Editorial Comment following this article.
  American Journal of Obstetrics and Gynecology, 1981